EcoDrugPlus

Ensembl ID : ENSUPAG00010019122
Gene Symbol: -
Cross references: -
82 Possible Orthologues:

Ensembl ID : ENSUPAG00010019640
Gene Symbol: -
Cross references: -
419 Possible Orthologues:

Ensembl ID : ENSUPAG00010019680
Gene Symbol: -
Cross references: -
282 Possible Orthologues:

Ensembl ID : ENSUPAG00010022427
Gene Symbol: -
Cross references: -
419 Possible Orthologues:

Ensembl ID : ENSUPAG00010022560
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSUPAG00010023340
Gene Symbol: -
Cross references: -
238 Possible Orthologues:

Ensembl ID : ENSUPAG00010000395
Gene Symbol: -
Cross references: -
255 Possible Orthologues:

Ensembl ID : ENSUPAG00010010577
Gene Symbol: -
Cross references: -
119 Possible Orthologues:

Ensembl ID : ENSUPAG00010003237
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSUPAG00010002075
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSUPAG00010000915
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Ensembl ID : ENSUPAG00010004106
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).